Novel cross-protective (universal) vaccine for influenza infections

针对流感感染的新型交叉保护（通用）疫苗

• 批准号: 256965
• 负责人: Agrawal Babita
• 金额: $ 11.66万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-02-01 至 2013-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=256965&lang=en
• 关键词: Conserved Antigen; Influenza; Tlr Agonists; Universal Vaccine

Influenza viruses cause seasonal yearly epidemics affecting people of all ages, resulting in thousands of deaths and hospitalizations each year worldwide. There have been three influenza pandemics in the last century, each leading to millions of deaths w

流感病毒引起季节性的年度流行病，影响所有年龄的人，导致全世界每年数千人死亡和住院治疗。 在上个世纪发生了三次流感大流行，每次都导致数百万人死亡。